Abstract
BackgroundTargeted and effective treatment options are needed for solid tumors, including glioblastoma (GBM), where survival rates with standard treatments are typically less than 2 years from diagnosis. Solid tumors pose...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have